Thermal ablation: Cost-effective and safe for the treatment of cervical precancer

In its seventh Evidence Summary Brief, IARC highlights key findings from multiple studies conducted in research and programmatic settings that generated evidence on the efficacy, safety, feasibility, scalability, and cost–effectiveness of thermal ablation. This new Evidence Summary Brief calls on policy-makers to continue supporting the deployment of the device, particularly in low- and middle-income countries.

This IARC Evidence Summary Brief is the seventh in a series of scientific Evidence Summary Briefs published by IARC to call attention to the findings of evidence-based studies in key aspects of cancer prevention.

IARC Press Release 373

Thermal ablation: Cost-effective and safe for the treatment of cervical precancer, IARC Evidence Summary Brief No. 7

IARC Evidence Summary Briefs series